These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25351768)

  • 1. Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane-Induced Death by AS101 via Inhibition of the VLA-4-IL10-Survivin Axis.
    Danoch H; Kalechman Y; Albeck M; Longo DL; Sredni B
    Mol Cancer Res; 2015 Mar; 13(3):411-22. PubMed ID: 25351768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.
    Sredni B; Weil M; Khomenok G; Lebenthal I; Teitz S; Mardor Y; Ram Z; Orenstein A; Kershenovich A; Michowiz S; Cohen YI; Rappaport ZH; Freidkin I; Albeck M; Longo DL; Kalechman Y
    Cancer Res; 2004 Mar; 64(5):1843-52. PubMed ID: 14996748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
    Hayun M; Naor Y; Weil M; Albeck M; Peled A; Don J; Haran-Ghera N; Sredni B
    Biochem Pharmacol; 2006 Nov; 72(11):1423-31. PubMed ID: 16889755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox modulation of adjacent thiols in VLA-4 by AS101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state.
    Layani-Bazar A; Skornick I; Berrebi A; Pauker MH; Noy E; Silberman A; Albeck M; Longo DL; Kalechman Y; Sredni B
    Cancer Res; 2014 Jun; 74(11):3092-103. PubMed ID: 24699624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
    Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
    Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways.
    Kalechman Y; Longo DL; Catane R; Shani A; Albeck M; Sredni B
    Int J Cancer; 2000 Apr; 86(2):281-8. PubMed ID: 10738258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulating tellurium compounds as anti-cancer agents.
    Sredni B
    Semin Cancer Biol; 2012 Feb; 22(1):60-9. PubMed ID: 22202556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.
    Kalechman Y; Gafter U; Weinstein T; Chagnac A; Freidkin I; Tobar A; Albeck M; Sredni B
    J Biol Chem; 2004 Jun; 279(23):24724-32. PubMed ID: 15001575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma.
    Kalechman Y; Shani A; Dovrat S; Whisnant JK; Mettinger K; Albeck M; Sredni B
    J Immunol; 1996 Feb; 156(3):1101-9. PubMed ID: 8557985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101.
    Kalechman Y; Sredni B; Weinstein T; Freidkin I; Tobar A; Albeck M; Gafter U
    J Am Soc Nephrol; 2003 Mar; 14(3):620-30. PubMed ID: 12595497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.
    Kim JH; Kim WS; Park C
    BMC Cancer; 2019 Oct; 19(1):936. PubMed ID: 31601188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway.
    Vishwakarma P; Parmar N; Chandrakar P; Sharma T; Kathuria M; Agnihotri PK; Siddiqi MI; Mitra K; Kar S
    Cell Mol Life Sci; 2018 Feb; 75(3):563-588. PubMed ID: 28900667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.
    Bhattacharyya J; Mihara K; Ohtsubo M; Yasunaga S; Takei Y; Yanagihara K; Sakai A; Hoshi M; Takihara Y; Kimura A
    Cancer Sci; 2012 Jan; 103(1):34-41. PubMed ID: 21999765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
    Kalechman Y; Gafter U; Gal R; Rushkin G; Yan D; Albeck M; Sredni B
    J Immunol; 2002 Jul; 169(1):384-92. PubMed ID: 12077268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase Fer.
    Hayun R; Shpungin S; Malovani H; Albeck M; Okun E; Nir U; Sredni B
    Ann N Y Acad Sci; 2007 Jan; 1095():240-50. PubMed ID: 17404037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
    Kalechman Y; Sredni B
    J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
    Lyu H; Wang S; Huang J; Wang B; He Z; Liu B
    Cancer Lett; 2018 Apr; 420():97-108. PubMed ID: 29409974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.